Literature DB >> 7471112

Toxicity of spirogermanium in mice and dogs after iv or im administration.

M C Henry, E Rosen, C D Port, B S Levine.   

Abstract

Toxicity of single-dose spirogermanium was evaluated after iv and im administration to CDF1 mice and beagle dogs. The im LD50 in mice was approximately threefold greater than the iv LD50. The lethal dose in dogs was the same for both routes of administration, but death was delayed after im injection. Convulsive seizures occurred only after the im doses that were lethal, but they were observed after administration of iv doses that were nonlethal. Microscopic evidence of drug toxicity (necrosis and degeneration) was found in mitotically active tissues: intestinal tract, lymphoid tissue, and bone marrow. Necrosis, hemorrhage, edema, and granulation tissue were observed in the muscle injection site.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7471112

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  3 in total

1.  Spirogermanium: a new investigational drug of novel structure and lack of bone marrow toxicity.

Authors:  M Slavik; O Blanc; J Davis
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

Review 2.  Complexes of metals other than platinum as antitumour agents.

Authors:  P Köpf-Maier
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

3.  A Phase I trial of spirogermanium administered on a continuous infusion schedule.

Authors:  P V Woolley; J D Ahlgren; P J Byrne; V M Priego; P S Schein
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.